Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $106 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $355 | - | In Stock | |
| 25 mg | $712 | - | In Stock | |
| 50 mg | $1,130 | - | In Stock |
| Description | BQ-788 sodium salt is a potent and selective antagonist of the Endothelin receptor type B, inhibiting the binding of Endothelin-1 to the receptor at nanomolar concentrations (reported IC₅₀ ≈ 1.2 nM). |
| Targets & IC50 | ETB:1.2 nM |
| In vitro | BQ-788 sodium salt potently and competitively inhibits 125I-labeled ET-1 binding to ETB receptors in human Girrardi heart cells (hGH) with an IC50 of 1.2 nM, while poorly inhibiting ETA receptor binding in human neuro-blastoma cell line SK-N-MC cells (IC50, 1300 nM). BQ-788 sodium salt inhibits ET-1 bioactivities, including bronchoconstriction, cell proliferation, and clearance of perfused ET-1[1], and shows no agonistic activity up to 10 μM. BQ-788 sodium salt competitively inhibits vasoconstriction induced by an ETB-selective agonist (pA2, 8.4). |
| In vivo | Administered intravenously at a dosage of 3 mg/kg/h, BQ-788 sodium salt effectively blocks the ETB receptor-mediated depressor responses induced by pharmacological levels of ET-1 or sarafotoxin6c (0.5 nmol/kg) in conscious rats, without affecting pressor responses. In Dahl salt-sensitive hypertensive rats, this dosage of BQ-788 sodium salt Results: in a significant increase in blood pressure, approximately 20 mm Hg. BQ-788 sodium salt is noted to inhibit ET-1-induced bronchoconstriction, tumor proliferation, and lipopolysaccharide-triggered organ failure [1]. BQ-788 sodium salt shifts the ET-1 dose-response curve eightfold to the left, highlighting a substantial role of ETB dilator receptors [2]. BQ-788 sodium salt significantly raises plasma ET-1 levels, indicating its potential as an ETB receptor blocker in vivo. In mice, intraplantar administration of 30 nmol BQ-788 sodium salt reduces mechanical and thermal hyperalgesia, oedema, and myeloperoxidase activity by significant margins, alongside diminishing overt pain-like behaviors. |
| Molecular Weight | 664.80 |
| Formula | C34H51N5NaO7 |
| Cas No. | 156161-89-6 |
| Smiles | O=C(N1[C@H](CCC[C@H]1C)C)N[C@@H](CC(C)(C)C)C(N[C@@H](C(N[C@@H](C([O-])=O)CCCC)=O)CC2=CN(C(OC)=O)C3=CC=CC=C23)=O.[Na+] |
| Relative Density. | no data available |
| Storage | Keep away from direct sunlight,Store under nitrogen Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 20.00 mg/mL (30.08 mM), Sonication is recommended. H2O: 40.00 mg/mL (60.17 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.30 mg/mL (4.96 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.